|
| |
Articles
1-300 out of 500 article(s) next
| Title |
Author |
Type |
Date |
Words |
| Impact of disease-specific orientation on new graduate nurse satisfaction and knowledge retention. |
Ballard, Julie; Mead, Cindy; Richardson, Deborah; Lotz, Abby |
|
May 31, 2012 |
4017 |
| An evaluation of stroke education in AVAIL registry hospitals. |
West, Angie; Cox, Margueritte; Zimmer, Louise O.; Fedder, Wende; Weber, Cheryl; Drew, Laura; Peterso |
|
May 29, 2012 |
6418 |
| Pill for irregular heartbeat shown green flag. |
|
|
May 23, 2012 |
533 |
| Study of First-in-Class WATCHMAN Device Shows 75 Percent Reduction in Stroke Risk in Patients With Atrial Fibrillation not Eligible for Oral Anticoagulation Therapy. |
|
|
May 14, 2012 |
1345 |
| Study of First-in-Class WATCHMAN Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy. |
|
|
May 11, 2012 |
1624 |
| Preliminary Results of Prospective Trial Suggest Warfarin May Be a Safer Option for Patients than Alternative Therapies. |
|
|
May 4, 2012 |
848 |
| Naturopathic management of infections of the heart and their sequelae. |
Mikolai, Jeremy; Wilner, Martin |
Clinical report |
May 1, 2012 |
8211 |
| United Arab Emirates : GLORIA TM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced. |
|
|
Apr 21, 2012 |
420 |
| United Arab Emirates : Leading medical and patient organisations join forces to improve stroke prevention in atrial fibrillation. |
|
|
Apr 19, 2012 |
458 |
| Despite Gaining FDA Approval within the Past Year, Bayer/Janssen's Xarelto and Astrazeneca's Brilinta Are Already Well Represented on Hospital Formularies, According to a Recent BioTrends Report. |
|
|
Apr 2, 2012 |
615 |
| Stroke guidelines under development. |
Ault, Alicia |
|
Apr 1, 2012 |
706 |
| Largest Warfarin Patient Self-Testing Study Results Establish New Standard of Care. |
|
Clinical report |
Mar 27, 2012 |
838 |
| German Left Atrial Appendage Device Market to Challenge Novel Anticoagulants. |
|
|
Mar 7, 2012 |
656 |
| Paediatric anticoagulation guidelines. |
Schapkaitz, E.; Sherman, G.G.; Jacobson, B.F.; Haas, S.; Buller, H.R.; Davies, V.; Diar, H.; Peters, |
Report |
Mar 1, 2012 |
3710 |
| Gastric outlet obstruction secondary to spontaneous intramural haematoma as a complication of warfarin treatment. |
Arain, J.; Al-Dabbagh, A. |
Case study |
Mar 1, 2012 |
1201 |
| Aspirin, warfarin equal in heart failure. |
Zoler, Mitchel L. |
|
Feb 15, 2012 |
1006 |
| Bleeding more likely from warfarin than rivaroxaban. |
Sullivan, Michele G. |
|
Feb 15, 2012 |
767 |
| Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome p450 enzymes by bilobalide in mice. |
Taki, Yuko; Yokotani, Kaori; Yamada, Shizuo; Shinozuka, Kazumasa; Kubota, Yoko; Watanabe, Yasuo; Ume |
Report |
Feb 15, 2012 |
5497 |
| New anti-clotting pill better at cutting stroke risk than old treatments. |
|
|
Feb 3, 2012 |
141 |
| New stroke-prevention drugs spur a-fib guides. |
Splete, Heidi |
|
Feb 1, 2012 |
472 |
| Do-it-yourself anticoagulation can be safe and effective. |
|
|
Feb 1, 2012 |
231 |
| Janssen Research Submits Application to FDA. |
|
|
Jan 31, 2012 |
1197 |
| 'Antithrombotic Drug Market Will Rise to 24.4 Billion Dollars in 2015' Says Visiongain. |
|
|
Jan 19, 2012 |
2016 |
| Exciting development helps patients get better, safer care closer to home; Dr Paul Myres explains the latest 1,000 Lives Plus work to diagnose and improve the care of patients with irregular heartbeats. |
|
|
Jan 16, 2012 |
614 |
| Immune response of broiler chickens fed diets supplemented with different level of chromium methionine under heat stress conditions. |
Ebrahimzadeh, S.K.; Farhoomand, P.; Noori, K. |
Report |
Jan 7, 2012 |
3152 |
| Molecular architecture of heparin and heparan sulfate: recent developments in solution structural studies. |
Mulloy, Barbara; Khan, Sanaullah; Perkins, Stephen J. |
Report |
Jan 1, 2012 |
5599 |
| Same-day discharge after percutaneous coronary intervention in light of the society for cardiovascular angiography and intervention's proposed guidelines: a single-center experience. |
Khouri, Yazan; Jain, Sachin Kumar Amruthlal; Serajian, Asif; Shaw, Michael; Zughaib, Marcel |
Clinical report |
Jan 1, 2012 |
2871 |
| Aspirin slashed blood clot recurrence by 40%. |
Brunk, Doug |
|
Jan 1, 2012 |
652 |
| Fondaparinux-associated heparin-induced thrombocytopenia. |
Burch, Micah; Cooper, Barry |
Clinical report |
Jan 1, 2012 |
1820 |
| inThought Report Says New Wave of Cardiology Drugs to Be Big Boon. |
|
|
Dec 20, 2011 |
1249 |
| Bayer's Xarelto (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis. |
|
|
Dec 19, 2011 |
1718 |
| ThromboGenics and BioInvent Complete Enrollment of Phase IIb Trial With TB-402 Ahead of Schedule. |
|
|
Dec 16, 2011 |
1392 |
| ThromboGenics and BioInvent Complete Enrolment of Phase IIb Trial with TB-402 ahead of schedule. |
|
|
Dec 16, 2011 |
1282 |
| MAJOR improvements are needed in [...]. |
|
|
Dec 12, 2011 |
156 |
| MAJOR improvements are needed in [...]; HEALTH IN BRIEF... |
|
|
Dec 5, 2011 |
106 |
| Inpatient anticoagulation. |
|
Book review |
Dec 1, 2011 |
141 |
| Pregnancy-induced osteomalasia: case report/Gebeligin tetikledigi osteomalazi: olgu sunumu. |
Ozgen, Merih; Armagan, Onur |
Case study |
Dec 1, 2011 |
1961 |
| Eisai Announce Japan Launch of Oral Anticoagulant Warfarin Granules 0.2%. |
|
|
Nov 30, 2011 |
464 |
| Research and Markets: Inpatient Anticoagulation. The First Practical Guide for Hospitalists on the Use of Anticoagulants in Hospitalized Patients. |
|
|
Nov 22, 2011 |
411 |
| Fitch: New Use of JNJ Blood Thinner Could Thicken Cash. |
|
|
Nov 15, 2011 |
424 |
| Rivaroxaban passes for stroke prevention. |
|
|
Nov 15, 2011 |
178 |
| FDA Approves XARELTO (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation. |
|
|
Nov 4, 2011 |
3122 |
| SMH-Kobernick Anchin Open Specialty Clinic to Help People Safely Manage Blood Thinner Medications. |
|
|
Nov 2, 2011 |
722 |
| Anti-Clotting Drugs Do Not Increase Bleeding Risk in GI Procedure, Mayo Study Finds. |
|
Clinical report |
Nov 1, 2011 |
477 |
| Retropharyngeal haematoma - an unusual cause of airway obstruction. |
Lin, M.J.; Sinclair, C. |
Case study |
Oct 21, 2011 |
834 |
| Canyon Pharmaceuticals Honored with Frost & Sullivan Award for Product Differentiation Excellence in Parenteral Anticoagulants. |
|
|
Oct 18, 2011 |
431 |
| The Atrial Fibrillation Drug Market Will Increase Nearly Eight-Fold over the Next Decade, Growing from $1.3 Billion in 2010 to over $10 Billion in 2020. |
|
|
Oct 18, 2011 |
553 |
| The impact of a statewide stroke quality improvement program: Colorado Stroke Alliance and Colorado Stroke Registry. |
Murphy, Paul; Smith, Don; Vislosky, Michael; Tripputi, Mark; Cumbler, Ethan; Blakie, Julie; Wilde, M |
|
Oct 1, 2011 |
3493 |
| Nutrition hotline. |
Mangels, Reed |
|
Oct 1, 2011 |
969 |
| Hemostasis test compatibility with capped and uncapped tubes. |
Finnegan, Kathleen; Cutsforth, Gwyn |
Report |
Sep 22, 2011 |
2325 |
| Surveyed U.S. Cardiologists Say That Superior Stroke Prevention Efficacy and Less Major Bleeding Than Warfarin Would Propel Apixaban to Capture the Leading Patient Share of New Anticoagulants for Atrial Fibrillation. |
|
|
Sep 14, 2011 |
628 |
| New hope for stroke victims in the North; Drug available from today for AF sufferers. |
|
|
Sep 5, 2011 |
587 |
| New hope for stroke victims. |
|
|
Sep 5, 2011 |
215 |
| First anti-stroke pill in 50 years goes on sale. |
|
|
Sep 5, 2011 |
300 |
| Anticoagulation therapy as a supplement to recanalization for the treatment of sigmoid sinus thrombosis: a case report. |
Rosenberg, Joshua D.; Parikh, Sanjay R. |
Case study |
Sep 1, 2011 |
1421 |
| New anticoagulant pill cuts stroke deaths by 11 pc. |
|
|
Aug 29, 2011 |
274 |
| Research and Markets: Will Next Generation Oral Anticoagulants Replace Warfarin as Mainstay Therapy? |
|
|
Aug 25, 2011 |
467 |
| HOPE OVER HEART PILL. |
|
|
Aug 11, 2011 |
142 |
| Stroke preventative drug launched. |
Khobetsi, Lorato |
|
Aug 5, 2011 |
313 |
| A program to improve secondary stroke prevention: the Colorado Neurological Institute stroke preventing recurrence of thromboembolic events through coordinated treatment program. |
Menard, Michelle M.; Smith, Don B.; Taormina, Cristina |
Clinical report |
Aug 1, 2011 |
3857 |
| Direct thrombin inhibitors: clinical uses, mechanism of action, and laboratory measurement. |
Rhea, Jeanne M. |
|
Aug 1, 2011 |
2854 |
| Enrollment Objective Achieved for Aspirin and Clopidogrel Patient Group of the On-X Heart Valve Anticoagulation Clinical Study. |
|
Clinical report |
Jul 26, 2011 |
895 |
| NY: Drs. fail to give anticoagulant to a-fib pt.: Denial of Drs.' motion for judgment affirmed. |
|
Case overview |
Jul 1, 2011 |
435 |
| Multimedia: FDA Approves XARELTO (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery. |
|
|
Jul 1, 2011 |
1939 |
| Documentation of physiological parameters and blood profile in newly born Kajli lambs. |
Saddiqi, H.A.; Nisa, M.; Mukhtar, N.; Shahzad, M.A.; Jabbar, A.; Sarwar, M. |
Report |
Jul 1, 2011 |
4915 |
| Effects of fermented soybean meal on immune response of weaned calves with experimentally induced lipopolysaccharide challenge. |
Kwon, In Hyuk; Kim, Myung Hoo; Yun, Cheol-Heui; Go, Jong Yeol; Lee, Chan Ho; Lee, Hyun June; Phipek, |
Report |
Jul 1, 2011 |
4644 |
| The relation between physiological parameters and the anxiety state in competitive men handball players during official competitions. |
Acsinte, Alexandru; Alexandru, Eftene; Pacuraru, Alexandru; Ghervan, Petru; Mihaila, Ion |
Report |
Jul 1, 2011 |
3110 |
| Four Clinical Trials Document the On-X Heart Valve's Exceptional Clinical Performance. |
|
Clinical report |
Jun 27, 2011 |
770 |
| Endotis Intiates Phase IIa Study of First-in-Class Neutralizable Anticoagulant in Open-Heart Surgery. |
|
|
Jun 22, 2011 |
439 |
| ELIQUIS[R] (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study. |
|
Clinical report |
Jun 22, 2011 |
1217 |
| Anticoagulant medication bivalirudin improves survival in heart attack. |
|
Clinical report |
Jun 14, 2011 |
447 |
| Pharmigene Secures Patents in Europe, Japan, New Zealand, Mexico, Singapore, and Taiwan Related to VKORC1-1639 as a Predictor to Patients' Sensitivity to Warfarin. |
|
|
Jun 2, 2011 |
451 |
| Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. |
Ntusi, Ntobeko B.A.; Badri, Motasim; Gumedze, Freedom; Wonkam, Ambroise; Mayosi, Bongani M. |
Report |
Jun 1, 2011 |
5029 |
| J Zoo Wildl Med.: Anticoagulant rodenticide exposure and toxicosis in four species of birds of prey presented to a wildlife clinic in Massachusetts, 2006-2010. |
Murray, M. |
Brief article |
Jun 1, 2011 |
252 |
| Study on Cammomile (Matricaria chamomilla L.) usage and farming. |
Mohammad, Sharrif moghaddasi |
Report |
Jun 1, 2011 |
5062 |
| Warfarin recalled. |
|
|
May 15, 2011 |
123 |
| On-X Life Technologies, Inc. to Host Satellite Symposium at American Association for Thoracic Surgery Meeting. |
|
|
May 5, 2011 |
627 |
| PolyMedix Presents Data on PMX-60056 at the American Heart Association ATVB-2011 Meeting. |
|
|
May 3, 2011 |
1006 |
| Effect of supplementing betaine on performance, carcass traits and immune responses in broiler chicken fed diets containing different concentrations of methionine. |
Rao, S.V. Rama; Raju, M.V.L.N.; Panda, A.K.; Saharia, Poonam; Sunder, G. Shyam |
Report |
May 1, 2011 |
6097 |
| Why am I always cold? |
|
Brief article |
May 1, 2011 |
109 |
| Effects of clove extract as an anesthetic on sperm motility traits and some hematological parameters in Prussian carp Carassius gibelio. |
Farahi, Amin; Kasiri, Milad; Talebi, Amir; Sudagar, Mohammad |
Report |
May 1, 2011 |
2193 |
| Too thin for comfort: a red-blooded medical challenge: creating a safer treatment to counteract the effect of blood thinners. |
Thaler, Sebastian |
|
May 1, 2011 |
1925 |
| Secondary prevention of stroke. |
Golden, William E.; Hopkins, Robert H. |
|
May 1, 2011 |
871 |
| ThromboGenics and BioInvent Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis. |
|
|
Apr 27, 2011 |
1557 |
| BioInvent and ThromboGenics Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis. |
|
|
Apr 27, 2011 |
1461 |
| Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA(R) (Edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism After Major Orthopedic Surgery. |
|
|
Apr 22, 2011 |
1200 |
| Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery. |
|
|
Apr 22, 2011 |
1072 |
| Research and Markets: Essential Strategic Insight for Key Stakeholders in the Anticoagulants Market. |
|
|
Apr 15, 2011 |
349 |
| Radix/Rhizoma Notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. |
He, Li; Chen, Xiaoyan; Zhou, Muke; Zhang, Dongping; Yang, Jie; Yang, Mi; Zhou, Dong |
Report |
Apr 15, 2011 |
4457 |
| Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright in vitro and in vivo. |
Gong, Guohua; Qin, Yuan; Huang, Wen |
Report |
Apr 15, 2011 |
5446 |
| Secondary prevention of stroke. |
Golden, William E.; Hopkins, Robert H. |
|
Apr 15, 2011 |
814 |
| MORE than a million people [...]. |
|
|
Apr 11, 2011 |
257 |
| On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence toward Maintaining Patients with Less Warfarin. |
|
|
Apr 6, 2011 |
995 |
| In Study of Acutely Ill Patients Rivaroxaban Compares Favorably With Enoxaparin in Preventing Venous Thromboembolism but With an Increased Rate of Bleeding. |
|
Report |
Apr 5, 2011 |
1613 |
| In Europe, Emerging Novel Factor Xa Inhibitors Are Set to Displace Use of Low-Molecular-Weight Heparins and Unfractionated Heparins in the Management of Ischemic Complications Associated with Acute Coronary Syndrome. |
|
Disease/Disorder overview |
Apr 5, 2011 |
587 |
| Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System. |
|
|
Apr 3, 2011 |
1369 |
| Nephrectomy in patients with Caroli's and ADPKD may be associated with increased morbidity. |
Aguilar, Martin; Meterissian, Sarkis; Levesque, Sebastien; Andonian, Sero |
Case study |
Apr 1, 2011 |
2057 |
| Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA. |
|
Financial report |
Mar 28, 2011 |
833 |
| More Than 50 Percent of Surveyed Orthopedic Surgeons and 70 Percent of Surveyed MCO Pharmacy Directors Chose Sanofi-Aventis's Lovenox as the Most Effective Anticoagulant for VTE Primary Prophylaxis, When Compared to Other Available Therapies. |
|
|
Mar 22, 2011 |
768 |
| Apixaban trumps aspirin in reducing stroke. |
Smith, Jennie |
Clinical report |
Mar 1, 2011 |
625 |
| Study finds racial disparity in AF awareness. |
Jancin, Bruce |
Clinical report |
Mar 1, 2011 |
252 |
| Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trials. |
Shih, Regina A.; Griffin, Beth Ann; Salkowski, Nicholas; Jewell, Adria; Eibner, Christine; Bird, Chl |
Report |
Mar 1, 2011 |
8392 |
| New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin in Reducing Stroke and Systemic Embolism in Patients with Atrial Fibrillation Unsuitable for Warfarin Therapy. |
|
|
Feb 10, 2011 |
2033 |
| PolyMedix Initiates Phase 2 Clinical Trial with Novel Heptagonist, PMX-60056. |
|
|
Feb 9, 2011 |
1136 |
| Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. |
Alsaikhan, Bader; Andonian, Sero |
Report |
Feb 1, 2011 |
3938 |
| Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. |
Casey, Georgina |
Report |
Feb 1, 2011 |
4569 |
| Risk behaviour of lead-exposed workers and hearing impairment. |
Galal, Salma; El-Samra, Gamal H.; Mazhar, Manal; El-Kholy, Fatma; Hegazy, Amel |
Report |
Feb 1, 2011 |
3374 |
| Annual Market Potential for LAA Occlusion/Exclusion is $500 Million in the US, According to Millennium Research Group. |
|
|
Jan 19, 2011 |
589 |
| Effect of antioxidants on physio-biochemical and hematological parameters in broiler chicken at high altitude. |
Biswas, A.; Ahmed, M.; Bharti, V.K.; Singh, S.B. |
Report |
Jan 13, 2011 |
2647 |
| New Drug Application Submitted to FDA for Rivaroxaban for Prevention of Stroke in Patients with Atrial Fibrillation. |
|
|
Jan 5, 2011 |
627 |
| New anticlotting drug. |
Zipes, Douglas P. |
Brief article |
Jan 1, 2011 |
114 |
| New option for atrial fibrillation. |
Acklin, Cara |
Brief article |
Jan 1, 2011 |
130 |
| Strict Heart Rate Control Provides No Advantage Over Lenient Approach. |
|
|
Dec 20, 2010 |
1427 |
| Evaluation of a pediatric blood filter for whole blood transfusions in domestic chickens (Gallus gallus). |
Jankowski, Gwen; Nevarez, Javier |
Report |
Dec 1, 2010 |
4702 |
| Anticoagulants, antiplatelets, and thrombolytics, 2d ed. |
|
Book review |
Dec 1, 2010 |
109 |
| The effect of motivational interviewing after ischemic stroke on patient knowledge and patient satisfaction with care: a pilot study. |
Byers, Ann Marie; Lamanna, Lenore; Rosenberg, Antonieta |
Report |
Dec 1, 2010 |
6744 |
| Pfizer halts blood thinner study due to bleeding. |
|
|
Nov 30, 2010 |
361 |
| Court says blood thinner was 'unreasonably dangerous'. |
|
|
Nov 30, 2010 |
435 |
| Bayer, J&J Anti-clot drug Excels in stroke trial. |
|
|
Nov 22, 2010 |
487 |
| PolyMedix Announces Three Presentations at Upcoming American Society of Hematology Meeting. |
|
|
Nov 22, 2010 |
958 |
| GAO says FDA risked integrity. |
|
|
Nov 16, 2010 |
668 |
| Anticoagulants curb prostate cancer mortality: aspirin leads the pack, lowering the death risk by nearly 50% in a study of more than 5,000 men. |
Sullivan, Michele G. |
Report |
Nov 15, 2010 |
770 |
| PolyMedix Presents PMX-60056 Clinical Data at the American Heart Association Scientific Sessions Meeting. |
|
Clinical report |
Nov 15, 2010 |
1479 |
| Boehringer Ingelheim GmbH's (Ingelheim DEU) Pradaxa blood thinner lowered the risk of major bleeding in patients taking the drug to prevent another stroke or stroke-like attack, according to a new analysis of a study. |
|
|
Nov 15, 2010 |
649 |
| Bayer AG's (leverkusen DEU) blood thinner Xarelto matched the standard therapy at preventing blood clots in patients with an irregular heartbeat, results that may determine its success in a market worth as much as $14 billion a year. |
|
|
Nov 8, 2010 |
240 |
| Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients. |
|
Clinical report |
Nov 8, 2010 |
1179 |
| PolyMedix Announces Acceptance of Two Presentations at the American Heart Association Meeting. |
|
|
Nov 4, 2010 |
899 |
| Scientific Protein Labs failed to report complaints about Chinese heparin: FDA. |
|
|
Nov 2, 2010 |
508 |
| B. Braun recalls heparin contaminated with oversulfated chondroitin sulfate. |
|
Brief article |
Nov 2, 2010 |
140 |
| Boehringer Ingelheim's Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3. |
|
|
Nov 1, 2010 |
1587 |
| Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management. |
|
|
Oct 29, 2010 |
490 |
| Aspirin use 'cuts risk of death from prostate cancer by more than half'. |
|
|
Oct 26, 2010 |
293 |
| PolyMedix Provides Updates on PMX-60056 Heptagonist Program. |
|
|
Oct 21, 2010 |
1861 |
| New Study Data Shows Advantages of GORE[R] PROPATEN[R] Vascular Grafts Compared with Standard ePTFE Grafts at One Year. |
|
Clinical report |
Oct 12, 2010 |
699 |
| Medical and surgical management of keloids: a review. |
Shockman, Soloman; Paghdal, Kapila V.; Cohen, George |
Report |
Oct 1, 2010 |
6200 |
| Coag tests get tweaked. |
Rogoski, Richard R. |
|
Oct 1, 2010 |
1077 |
| European Hospital Anticoagulant Market Dominated by Sanofi-Aventis's Clexane. |
|
|
Sep 28, 2010 |
426 |
| GenMark Diagnostics Selected as Diagnostic Platform in Warfarin Clinical Trial. |
|
Clinical report |
Sep 27, 2010 |
488 |
| pounds 2.5 million injection for blood clot technology; Massive investment put into hand-held monitor. |
|
|
Sep 15, 2010 |
564 |
| Apixaban bests aspirin for stroke reduction in AF. |
Jancin, Bruce |
|
Sep 15, 2010 |
890 |
| Natural anticoagulant levels in children with chronic liver disease/ Kronik karaciger hastaligi olan cocukluklarda dogal antikoagulan duzeyleri. |
Gulcan, E. Mahir; Kutlu, Tufan; Erkan, Tulay; Cokugras, Fugen Cullu |
Report |
Sep 1, 2010 |
2260 |
| DAIICHI SANKYO Announces Enrollment in the Two Largest Single Phase III Trials so far for the Prevention of Stroke in AF and for the Treatment of VTE is Proceeding as Planned. |
|
|
Sep 1, 2010 |
1514 |
| Deprivation of esophageal boluses and dry forage intake in large-type goats. |
Van Thang, Tran; Sunagawa, Katsunori; Nagamine, Itsuki; Kato, Seiyu |
Report |
Sep 1, 2010 |
7924 |
| Being under 45 raises VTE risk in cirrhosis. |
Napoli, Denise |
|
Sep 1, 2010 |
631 |
| Boca Raton Community Hospital First in Florida to Use New Device for Stroke Prevention in Atrial Fibrillation Patients. |
|
|
Aug 10, 2010 |
867 |
| Congressmen press Hamburg on Chinese heparin. |
|
|
Aug 10, 2010 |
437 |
| Raising awareness of heparin-induced thrombocytopenia in subarachnoid hemorrhage. |
Robinson, Jennifer D. |
Clinical report |
Aug 1, 2010 |
2180 |
| Standardized admission and discharge templates to improve documentation of the joint commission on accreditation of healthcare organization performance markers. |
Whited, Karen; Aiyagari, Venkatesh; Calderon-Arnulphi, Mateo; Cursio, John; Pandey, Dilip; Hillmann, |
Report |
Aug 1, 2010 |
2787 |
| Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. |
Lupidi, G.; Scire, A.; Camaioni, E.; Khalife, K.H.; De Sanctis, G.; Tanfani, F.; Damiani, E. |
Report |
Aug 1, 2010 |
6131 |
| United States : AstraZeneca asks FDA to approve its blood thinner. |
|
|
Jul 28, 2010 |
202 |
| United States : Market divided as FDA issues briefing information on AstraZeneca blood thinner. |
|
|
Jul 28, 2010 |
351 |
| United States : FDA Questions Effectivness Of AstraZeneca Anticlotting Drug. |
|
|
Jul 27, 2010 |
278 |
| CMS Approves Clinical Study of Genetic Test to Predict Patient Response to Leading Anticoagulant Drug Warfarin. |
|
|
Jul 26, 2010 |
826 |
| Germany : FDA approves generic blood thinner. |
|
|
Jul 26, 2010 |
420 |
| Eli Lilly pitches blood test to aid sales of blood thinner. Eli Lilly & Co. |
|
|
Jul 19, 2010 |
272 |
| Coumadin recalled for variations in active ingredient. |
|
Brief article |
Jul 13, 2010 |
215 |
| Positive Results from Phase II VTE Prophylaxis Study with TB-402 (Anti-Factor VIII) Presented at the 21st International Congress on Thrombosis in Milan, Italy. |
|
|
Jul 9, 2010 |
1419 |
| EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients. |
|
Clinical report |
Jul 6, 2010 |
816 |
| EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients. |
|
Clinical report |
Jul 6, 2010 |
812 |
| The effect of various concentrations of taurine during in vitro fertilization on the development of bovine embryos fertilized with spermatozoa from three different bulls. |
Tsuzuki, Yasuhiro; Toyama, Hitomi; Nabenishi, Hisashi; Morita, Tetsuo; Ashizawa, Koji |
Report |
Jul 1, 2010 |
5060 |
| Heart defect often causes no symptoms. |
Zipes, Douglas P. |
Brief article |
Jul 1, 2010 |
248 |
| The role of Phototherapy in cutaneous T-cell lymphoma. |
Pothiawala, Salma Z.; Baldwin, Brooke T.; Cherpelis, Basil S.; Lien, Mary H.; Fenske, Neil Alan |
Clinical report |
Jul 1, 2010 |
7353 |
| Heparinoides naturais isolados de rodoficeas (Halymenia sp.) arribadas na costa cearense. |
Gurgel Rodrigues, Jose Arievilo; Torres, Valeska Martins; de Alencar, Daniel Barroso; Holanda Sampai |
|
Jul 1, 2010 |
4643 |
| Editorial. |
Joyner, Kelly A., Jr. |
Editorial |
Jun 22, 2010 |
466 |
| Bristol-Myers Squibb Co. |
|
|
Jun 14, 2010 |
226 |
| Community stroke prevention programs: an overview. |
Kozub, Elizabeth |
Report |
Jun 1, 2010 |
5463 |
| The role of venous thrombectomy for ilio-femoral vein thrombosis. |
Matley, Philip |
|
Jun 1, 2010 |
1572 |
| Thrombolysis for deep venous thrombosis. |
Marle, J. Van |
Clinical report |
Jun 1, 2010 |
3546 |
| Pulmonary embolism. |
Muckart, David |
|
Jun 1, 2010 |
1688 |
| Vena caval filters: an evidence-based review. |
Paruk, Nishen |
Report |
Jun 1, 2010 |
2608 |
| CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation Testing System for Patient Home Use. |
|
|
Jun 1, 2010 |
725 |
| Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems. |
|
|
May 25, 2010 |
581 |
| Congress faults FDA in heparin case. |
|
|
May 18, 2010 |
372 |
| ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1501 |
| BioInvent and ThromboGenics Announce Positive Topline Results from Phase II VTE Prophylaxis Study with Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1255 |
| ThromboGenics and BioInvent Announce Positive Topline Results From Phase II VTE Prophylaxis Study With Anti-Factor VIII (TB-402). |
|
|
May 6, 2010 |
1508 |
| Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety Goal. |
|
|
May 6, 2010 |
1320 |
| Evaluation of Falcivax against Quantitative Buffy Coat (QBC) for the diagnosis of malaria. |
Gurung, Bimala; Bairy, Indira; Jagadishchandra; Manohar, Chetan |
Clinical report |
May 1, 2010 |
2863 |
| Effect of temperature storage on hematological parameters of Avian turkey blood. |
Hadzimusic, Nejra; Katica, Muhamed; Muharemovic, Zijad; Musanovic, Jasmin |
Clinical report |
May 1, 2010 |
2415 |
| EHSI to Add Blood Disorder Treatment Module to Medical iPhone App. |
|
|
Apr 26, 2010 |
557 |
| EHSI Initiates Selection of Protocols and Equipment for New Medical iPhone App. |
|
|
Apr 21, 2010 |
530 |
| Toddler may have died of heparin overdose. |
|
|
Apr 20, 2010 |
655 |
| Tests confirm that 'new' heparin is less potent. |
|
|
Apr 20, 2010 |
268 |
| Judge says Sanofi, Bristol can seek $442 million from Apotex. |
|
Brief article |
Apr 19, 2010 |
332 |
| Sulfated polysaccharides isolated from Caulerpa racemosa and Caulerpa cupressoides (Chlorophyceaes)--extraction, fractionation and anticoagulant activity/ Polissacarideos sulfatados isolados das cloroficeas Caulerpa racemosa e Caulerpa cupressoides--extracao, fracionamento e atividade anticoagulante. |
Rodrigues, Jose Arievilo Gurgel; Vanderlei, Edfranck de Sousa Oliveira; Quindere, Ana Luiza Gomes; F |
|
Apr 1, 2010 |
4672 |
| Intravenous orexin reduces LH secretion in castrated camelus dromedaries fed a sub-maintenance diet. |
Khazali, H. |
Report |
Apr 1, 2010 |
3716 |
| The Launches and Uptake of Novel Oral Anticoagulants Will Drive the Venous Thromboembolism Drug Market to Nearly Double by 2018. |
|
|
Mar 30, 2010 |
622 |
| AGA Medical Receives Conditional IDE Approval from FDA to Study Use of AMPLATZER[R] Cardiac Plug to Close the Left Atrial Appendage. |
|
|
Mar 24, 2010 |
1004 |
| [gamma]-LA-supplementation to IVC for IVP bovine embryos. |
Gaja, A.; Meng, C.L.; Sato, M.; Nakajima, T.; Kubota, C.; Kojima, T. |
Report |
Mar 23, 2010 |
5886 |
| An experimental blood thinner being developed by Merck & Co (Whitehouse Station NJ) from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses against widely used warfarin in patients with atrial fibrillation. |
|
|
Mar 22, 2010 |
322 |
| Anticoagulants plus acid-suppressive agents: an unsafe combination? |
|
|
Mar 22, 2010 |
335 |
| Pathway Genomics Responds to Medco, Mayo Clinic Study Revealing Gene Testing Reduces Hospitalization Rates for Warfarin Patients. |
|
|
Mar 17, 2010 |
497 |
| Hope for stroke victims. |
|
|
Mar 17, 2010 |
175 |
| Effects of polyurethane coated urea supplement on in vitro ruminal fermentation, ammonia release dynamics and lactating performance of Holstein dairy cows fed a steam-flaked corn-based diet. |
Xin, H.S.; Schaefer, D.M.; Liu, Q.P.; Axe, D.E.; Meng, Q.X. |
Report |
Mar 11, 2010 |
7112 |
| Warfarin users more vulnerable to brain bleeding after stroke treatment. |
|
|
Mar 9, 2010 |
409 |
| Pfizer Inc (New York) and Bristol-Myers Squibb Co's (New York) anti-clotting pill apixaban proved better than standard treatment Lovenox in a late-stage knee surgery trial, boosting prospects for the drug after earlier disappointment. |
|
Brief article |
Mar 8, 2010 |
113 |
| ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In The Prevention Of Venous Thromboembolism Following Knee Replacement Surgery. |
|
Clinical report |
Mar 4, 2010 |
1483 |
| Better blood thinner? |
Zipes, Douglas P. |
|
Mar 1, 2010 |
377 |
| Serum leptin levels in women with immunological recurrent abortion. |
Zarei, Saeed; Soltanghoraee, Haleh; Mohammadzadeh, Afsaneh; Arefi, Soheila; Zarnani, Amir Hassan; Id |
Report |
Mar 1, 2010 |
3478 |
| Leech therapy in cutaneous surgery and disease. |
Mamelak, Adam J.; Jackson, Adrianna; Nizamani, Rabia; Arnon, Ofer; Liegeois, Nanette J.; Redett, Ric |
Case study |
Mar 1, 2010 |
3917 |
| First Direct Thrombin Inhibitor for DVT Prevention Now Available From Canyon Pharmaceuticals. |
|
|
Mar 1, 2010 |
1151 |
| Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat. |
Wang, X.; Lee, W.Y.W.; Or, P.M.Y.; Yeung, J.H.K. |
Clinical report |
Mar 1, 2010 |
5784 |
| Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo. |
Wu, Windy W.P.; Yeung, John H.K. |
|
Mar 1, 2010 |
5474 |
| Lupus anticoagulant, antiphospholipid syndrome and cardiac surgery. |
Cartwright, B.L.; Bean, M.; Cooper, J.O. |
Case study |
Mar 1, 2010 |
3092 |
| Woodcock cleared of conflict-of-interest allegations in heparin case. |
|
|
Feb 9, 2010 |
534 |
| Excelsior Medical's New Catheter Lock Solution Approved by Health Canada. |
|
|
Feb 9, 2010 |
489 |
| Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 causes of death in the U.S. |
|
Clinical report |
Feb 8, 2010 |
1004 |
| Genetic diversity of a Chinese native chicken breed, Bian chicken, based on twenty-nine microsatellite markers. |
Ding, Fu-Xiang; Zhang, Gen-Xi; Wang, Jin-Yu; Li, Yuan; Zhang, Li-Jun; Wei, Yue Wang, Hui-Hua; Zhang, |
Report |
Feb 1, 2010 |
5522 |
| A historical account of stroke and the evolution of nursing care for stroke patients. |
Nilsen, Marci Lee |
Report |
Feb 1, 2010 |
6810 |
| The management of seizures in brain tumor patients. |
Smith, Kristen Catherine |
Report |
Feb 1, 2010 |
8532 |
| Aspirin fails to prevent recurrent miscarriages. |
Macneil, Jane Salodof |
|
Feb 1, 2010 |
1303 |
| Amphastar files new appeal in FDA conflict-of-interest case. |
|
|
Jan 26, 2010 |
531 |
| Baxter faces dozens of new suits over tainted heparin. |
|
|
Jan 26, 2010 |
365 |
| ARYx Therapeutics Receives Guidance on Anticoagulant Agent Tecarfarin. |
|
|
Jan 5, 2010 |
1427 |
| [gamma]-LA-supplementation to IVC for IVP bovine embryos. |
Gaja, A.; Meng, C.L.; Sato, M.; Nakajima, T.; Kubota, C.; Kojima, T. |
Report |
Jan 1, 2010 |
5886 |
| Intravenous orexin reduces LH secretion in castrated camelus dromedaries fed a sub-maintenance diet. |
Khazali, H. |
Report |
Jan 1, 2010 |
3716 |
| Dabigatran curbs bleeding in VTE prophylaxis. |
Wendling, Patrice |
Clinical report |
Jan 1, 2010 |
964 |
| Fixed-dose rivaroxaban slashes risk of recurrent VTE. |
London, Susan |
Clinical report |
Jan 1, 2010 |
470 |
| Heparin-induced thrombocytopenia (HIT): a case study. |
Newkirk, Catherine E. |
Case study |
Jan 1, 2010 |
4252 |
| Chinese poisons in your medicine cabinet. |
Schlafly, Phyllis |
|
Dec 22, 2009 |
766 |
| Research and Markets: Anticoagulants - A Global Market Review. |
|
Industry overview |
Dec 15, 2009 |
286 |
| Data on PolyMedix's Heptagonist Compounds to be Presented at Annual Meeting of the American Society of Hematology. |
|
|
Dec 7, 2009 |
586 |
| Phase III Study of Rivaroxaban Shows That Extending Anticoagulant Treatment by Six or 12 Months Significantly Reduced Risk of Second Symptomatic VTE. |
|
|
Dec 6, 2009 |
1246 |
| Anticoagulant may control localized prostate ca. |
Wendling, Patrice |
|
Dec 1, 2009 |
597 |
| Delayed deproteinization causes methodological errors in amino acid levels in plasma stored at room temperature or -20[degrees]C. |
Li, Junyou; Piao, Chunxiang; Jin, Huazi; Wongpanit, Kannika; Manabe, Noboru |
Report |
Dec 1, 2009 |
4096 |
| Consumer drug ads drive up health costs; study. |
|
|
Nov 30, 2009 |
346 |
| FDA says Prilosec can block benefits of Plavix. |
|
|
Nov 24, 2009 |
370 |
| FDA conducts directed inspection of Scientific Protein after heparin AEs. |
|
|
Nov 1, 2009 |
513 |
| The effects of the hot, humid tropical climate and early age feed restriction on stress and fear responses, and performance in broiler chickens. |
Al-Aqil, A.; Zulkifli, I.; Sazili, A.Q.; Omar, A.R.; Rajion, M.A. |
Report |
Nov 1, 2009 |
4936 |
| FDA conducts directed inspection of Scientific Protein after heparin AEs. |
Mashaw, Rebecca |
|
Nov 1, 2009 |
515 |
| Effectiveness of rheolytic thrombectomy during percutaneous revascularization for ST-segment elevation myocardial infarction: a single center experience with the AngioJet catheter. |
Hulse, Ronald S., III; Stauffer, Marc R.; Jain, Abnash C.; Beto, Robert; Warden, Bradford; Gharib, W |
Report |
Nov 1, 2009 |
3140 |
| POC PT/INR testing: a better choice for patients and providers. |
Huston, Tim |
|
Nov 1, 2009 |
1147 |
| Nadroparin Reduces Thromboembolic Events in Ambulatory Patients. |
|
Clinical report |
Oct 28, 2009 |
413 |
| ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402). |
|
Clinical report |
Oct 28, 2009 |
1387 |
| A sea change in anticoagulation therapy. |
Goldstein, Sidney |
Editorial |
Oct 15, 2009 |
577 |
| Change in heparin manufacturing will decrease potency, protect quality: FDA. |
|
|
Oct 13, 2009 |
522 |
| Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma. |
Fahl, Kelly N.; Poon, Stephen A.; Badani, Ketan K.; Benson, Mitchell C. |
Case study |
Oct 1, 2009 |
2123 |
| PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound. |
|
|
Sep 29, 2009 |
852 |
| Common anticoagulant may cause skin lesions. |
|
|
Sep 29, 2009 |
222 |
| Research and Markets: mediKOL Insight - Where Next for Thrombosis? |
|
|
Sep 22, 2009 |
636 |
| Dabigatran outperforms warfarin for atrial fibrillation. |
Zoler, Mitchel L. |
Clinical report |
Sep 15, 2009 |
760 |
| Edoxaban - Next Generation Oral Anticoagulant Under Investigation to Help Prevent Stroke in Patients With Atrial Fibrillation. |
|
|
Sep 1, 2009 |
1250 |
| Largest Registry to Date to Provide the First-Ever Picture of the Real Global Burden of Atrial Fibrillation (AF). |
|
|
Aug 31, 2009 |
851 |
| New drug reduces risk of strokes. |
|
|
Aug 31, 2009 |
121 |
| Wonder pill cuts heart deaths, says firm. |
|
|
Aug 31, 2009 |
377 |
| Promising Results of Drug Trial Could Herald a Replacement for Popular Blood Thinner, Reports Lankenau Cardiologist and Lead U.S. Researcher in Today's New England Journal of Medicine. |
|
|
Aug 31, 2009 |
1201 |
| Promising Results of Drug Trial Could Herald a Replacement for Popular Blood Thinner. |
|
|
Aug 31, 2009 |
451 |
| Largest Registry to Date to Provide the First-Ever Picture of the Real Global Burden of Atrial Fibrillation (AF). |
|
|
Aug 30, 2009 |
854 |
| 'Thick' blood causes as well as protects from heart attack, stroke. |
|
Clinical report |
Aug 25, 2009 |
418 |
| Effect of dietary energy level on nutrient utilization, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in plasma, liver and longissimus dorsi muscle in growing-finishing pigs using soybean oil as an energy source. |
Du, W.; Li, Y.J.; Zhao, G.Y.; Yin, Y.L.; Kong, X.F. |
Report |
Aug 1, 2009 |
4827 |
| Effects of major tanshinones isolated from Danshen (salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates. |
Wang, Xin; Lee, Wayne Y.W.; Or, Penelope M.Y.; Yeung, John H.K. |
Report |
Aug 1, 2009 |
6738 |
| ARYx Therapeutics Inc. |
|
Brief article |
Jul 13, 2009 |
106 |
| Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease. |
|
|
Jul 9, 2009 |
1150 |
| ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402. |
|
|
Jul 3, 2009 |
1348 |
| NY: failure to give Coumadin to at risk patient: plaintiff delayed too long in bring suit. |
Tammelleo, A. David |
|
Jul 1, 2009 |
588 |
| Changes in the activated cytotoxic suppressor T-lymphocytes in elderly patients with mediterranean spotted fever. |
Gospodinova, Margarita D.; Nenova, Marina A.; Mileva, Sevda S. |
Report |
Jul 1, 2009 |
2906 |
| Effects of sperm pretreatments and in vitro culture systems on development of in vitro fertilized embryos derived from prepubertal Boer goat oocytes in China. |
Lv, Lihua; Yue, Wenbin; Liu, Wenzhong; Ren, Youshe; Li, Fuzhong; Lee, Kyung-Bon; Smith, George W. |
Report |
Jul 1, 2009 |
5552 |
| Suitability of sainfoin (Onobrychis viciifolia) hay as a supplement to fresh grass in dairy cows. |
Scharenberg, A.; Kreuzer, M.; Dohme, F. |
Report |
Jul 1, 2009 |
8695 |
| Regular aspirin use may raise stroke risk for healthy people. |
|
|
Jun 21, 2009 |
510 |
| PolyMedix Receives $923,000 SBIR Grant to Support Development of LMWH Antagonists. |
|
|
Jun 12, 2009 |
747 |
| Johnson & Johnson and Germany's Bayer AG failed to win approval for a new anti-clotting pill to compete with Sanofi-Aventis SA's top-selling Lovenox shot. |
|
Brief article |
Jun 1, 2009 |
133 |
| Combination of Aspirin and an Anti-Clotting Drug Reduces Risk of Dialysis Access Failure. |
|
|
May 21, 2009 |
143 |
| Aspirin and anti-clotting drug's combo reduces dialysis access failure risk. |
|
|
May 21, 2009 |
314 |
| Endotis Pharma Reports Successful Completion of Phase I Program with EP42675, a First in Class Synthetic Parenteral Anticoagulant. |
|
|
May 19, 2009 |
435 |
| Delaware patients did not die due to heparin, Baxter says. |
|
|
May 19, 2009 |
331 |
| Osmetech's eSensor XT-8 platform wins Medical Design Excellence Award. |
|
|
May 14, 2009 |
721 |
| Osmetech Chosen as Principal Supplier for a Major Clinical Trial. |
|
|
May 13, 2009 |
872 |
| Common heartburn drugs may reduce anti-clotting medications' benefits. |
|
|
May 7, 2009 |
502 |
| Bristol-Myers Q1 profit beats estimates on strong drug sales. |
|
Financial report |
May 4, 2009 |
266 |
| TheraDoc Introduces Anticoagulation Alerts Package to Help Hospitals Meet New National Patient Safety Goal. |
|
|
Apr 14, 2009 |
761 |
| Plavix([R]) Plus Aspirin More Effective Than Aspirin Alone in Preventing Major Vascular Events in Patients with Atrial Fibrillation Who Cannot Take Oral Anticoagulants. |
|
Clinical report |
Mar 31, 2009 |
2060 |
| Popular acid blockers don't mix with anticlotting medication: reflux drugs might lessen protection from blood thinner. |
Seppa, Nathan |
|
Mar 28, 2009 |
500 |
| Bayer shares leap on US panel backing for Xarelto. |
|
Brief article |
Mar 23, 2009 |
271 |
| FDA Advisory Committee Finds Favorable Risk-Benefit Profile for Oral Anticoagulant Rivaroxaban for Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism After Hip or Knee Replacement Surgery. |
|
|
Mar 19, 2009 |
853 |
| NICE Recommends Xarelto(R) (Rivaroxaban) Use in NHS. |
|
|
Mar 5, 2009 |
1691 |
| Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. |
Feher, Gergely; Koltai, Katalin; Kesmarky, Gabor; Horvath, Beata; Toth, Kalman; Komoly, Samuel; Szap |
Clinical report |
Mar 1, 2009 |
4097 |
| ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis. |
|
|
Feb 23, 2009 |
1396 |
| Could Genetics Improve Warfarin Dosing? |
|
|
Feb 19, 2009 |
106 |
| Novartis AG's new partner Portola Pharmaceuticals Inc (South San Francisco CA) is in talks with other drugmakers about a blood thinner that works like German drugmaker Bayer AG's Xarelto, the company's finance chief said. |
|
Brief article |
Feb 16, 2009 |
204 |
| Advanced Diamond Technologies Enters Agreement with Jarvik Heart to Supply Diamond Coatings Engineered to Eliminate Blood Clotting in Heart Pumps. |
|
|
Feb 11, 2009 |
690 |
| FDA approves drug from Charlton goats; First from transgenic animals. |
|
|
Feb 7, 2009 |
581 |
| USP Announces New Standards to Protect Patients from Counterfeit and Adulterated Medicines. |
|
|
Feb 4, 2009 |
524 |
| Elsewhere, agency staff recommended Eli Lilly and Co. (Indianapolis IN) and Japan's Daiichi Sankyo Co Ltd.'s anti-clotting drug prasugrel for approval, saying its benefits outweigh bleeding risks. |
|
Brief article |
Feb 2, 2009 |
164 |
| Webcasts to Feature Discussions on Preventing HAIs and Pressure Ulcers, Implementing Anticoagulation Programs to Meet The Joint Commission Requirements. |
|
|
Feb 2, 2009 |
464 |
| Error rate high for anticoagulant therapy. |
|
|
Feb 1, 2009 |
330 |
| The spectrum of eosinophilic cystitis in males: case series and literature review. |
Popescu, Oana-Eugenia; Landas, Steve K.; Haas, Gabriel P. |
Report |
Feb 1, 2009 |
4164 |
| GTC Biotherapeutics Inc. |
|
Brief article |
Jan 19, 2009 |
118 |
| Standing Stone, Inc. Adds Inpatient Anticoagulation Management Capabilities to CoagClinic[TM] to Support the Joint Commission National Patient Safety Guidelines and Compliance Reporting. |
|
Company overview |
Jan 12, 2009 |
366 |
| Business briefs. |
|
|
Jan 9, 2009 |
380 |
| Blood thinners don't address long-term problems in Thrombosis patients. |
|
|
Dec 3, 2008 |
362 |
| Lupus anticoagulant positivity in autoimmune thyroid diseases/Otoimmun tiroid hastaliklarinda lupus antikoagulan pozitifligi. |
Celikci, Meftun; Hacihanefioglu, Abdullah; Turemen, Erdem; Tarkun, Pinar; Gonullu, Emel; Tarkun, Ilh |
Report |
Dec 1, 2008 |
2088 |
| Bayer AG. |
|
Clinical report |
Nov 17, 2008 |
230 |
| A heart stent that coats itself with human tissue kept arteries open without patients needing to take anti-clotting medications, a study found. |
|
Clinical report |
Nov 17, 2008 |
293 |
| Drug Development Company Glycotek Moves into the Hershey Center for Applied Research. |
|
|
Nov 10, 2008 |
519 |
| Diet, drugs may affect Coumadin. |
Zipes, Douglas P. |
|
Nov 1, 2008 |
337 |
| VTE prophylaxis--pros and cons. |
Woodruff, David W. |
Brief article |
Nov 1, 2008 |
262 |
| Warfarin Sensitivity Study Results Update on Proposed Issue of American Depositary Shares. |
|
|
Oct 31, 2008 |
315 |
| Angiomax(R) Reduced Cardiac Mortality by 43 Percent and Improved Overall Survival by 31 Percent at One-Year in HORIZONS-AMI Trial. |
|
|
Oct 15, 2008 |
1599 |
| The Medicines Company Announces HORIZONS-AMI 1-Year Data To Be Presented at 2008 TCT Meeting. |
|
|
Oct 14, 2008 |
1102 |
| Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years. |
|
|
Sep 24, 2008 |
2122 |
|
